Literature DB >> 21605702

miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes.

Harsh Dweep1, Carsten Sticht, Priyanka Pandey, Norbert Gretz.   

Abstract

MicroRNAs are small, non-coding RNA molecules that can complementarily bind to the mRNA 3'-UTR region to regulate the gene expression by transcriptional repression or induction of mRNA degradation. Increasing evidence suggests a new mechanism by which miRNAs may regulate target gene expression by binding in promoter and amino acid coding regions. Most of the existing databases on miRNAs are restricted to mRNA 3'-UTR region. To address this issue, we present miRWalk, a comprehensive database on miRNAs, which hosts predicted as well as validated miRNA binding sites, information on all known genes of human, mouse and rat. All mRNAs, mitochondrial genes and 10 kb upstream flanking regions of all known genes of human, mouse and rat were analyzed by using a newly developed algorithm named 'miRWalk' as well as with eight already established programs for putative miRNA binding sites. An automated and extensive text-mining search was performed on PubMed database to extract validated information on miRNAs. Combined information was put into a MySQL database. miRWalk presents predicted and validated information on miRNA-target interaction. Such a resource enables researchers to validate new targets of miRNA not only on 3'-UTR, but also on the other regions of all known genes. The 'Validated Target module' is updated every month and the 'Predicted Target module' is updated every 6 months. miRWalk is freely available at http://mirwalk.uni-hd.de/.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605702     DOI: 10.1016/j.jbi.2011.05.002

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  836 in total

1.  MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.

Authors:  Hao Fu; Hui-chan He; Zhao-dong Han; Yue-ping Wan; Hong-wei Luo; Ya-qiang Huang; Chao Cai; Yu-xiang Liang; Qi-shan Dai; Fu-neng Jiang; Wei-de Zhong
Journal:  Tumour Biol       Date:  2014-11-15

2.  Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.

Authors:  Charlotte Angerstein; Michael Hecker; Brigitte Katrin Paap; Dirk Koczan; Madhan Thamilarasan; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Neurobiol       Date:  2012-05-02       Impact factor: 5.590

Review 3.  MicroRNAs in liver disease.

Authors:  Xin Wei Wang; Niels H H Heegaard; Henrik Orum
Journal:  Gastroenterology       Date:  2012-04-11       Impact factor: 22.682

4.  Reduction of dietary glycaemic load modifies the expression of microRNA potentially associated with energy balance and cancer pathways in pre-menopausal women.

Authors:  Susan E McCann; Song Liu; Dan Wang; Jie Shen; Qiang Hu; Chi-Chen Hong; Vicky A Newman; Hua Zhao
Journal:  Br J Nutr       Date:  2012-05-30       Impact factor: 3.718

5.  Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells.

Authors:  Priya Samuel; Ryan Charles Pink; Daniel Paul Caley; James Michael Stevenson Currie; Susan Ann Brooks; David Raul Francisco Carter
Journal:  Tumour Biol       Date:  2015-09-19

6.  Inhibition of miR-486 and miR-92a decreases liver and plasma cholesterol levels by modulating lipid-related genes in hyperlipidemic hamsters.

Authors:  Loredan S Niculescu; Natalia Simionescu; Elena V Fuior; Camelia S Stancu; Mihaela G Carnuta; Madalina D Dulceanu; Mina Raileanu; Emanuel Dragan; Anca V Sima
Journal:  Mol Biol Rep       Date:  2018-05-03       Impact factor: 2.316

Review 7.  Integrating omics technologies to study pulmonary physiology and pathology at the systems level.

Authors:  Ravi Ramesh Pathak; Vrushank Davé
Journal:  Cell Physiol Biochem       Date:  2014-04-28

8.  Non-inhibited miRNAs shape the cellular response to anti-miR.

Authors:  John R Androsavich; B Nelson Chau
Journal:  Nucleic Acids Res       Date:  2014-05-07       Impact factor: 16.971

9.  An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality.

Authors:  Martha L Slattery; Jennifer S Herrick; Lila E Mullany; Nicola Valeri; John Stevens; Bette J Caan; Wade Samowitz; Roger K Wolff
Journal:  Int J Cancer       Date:  2014-12-16       Impact factor: 7.396

10.  miR-140-5p Attenuates Neuroinflammation and Brain Injury in Rats Following Intracerebral Hemorrhage by Targeting TLR4.

Authors:  Shunda Wang; Yujie Cui; Jiaqi Xu; Heng Gao
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.